bioMérieux distributes COPAN’s WASP® and WASPLab™ automated systems and speeds up deployment of its “FMLA® - Lab Efficiency” vision.
bioMérieux and Illumina Enter Agreement to Co-Develop a Next-Generation Sequencing Solution for Epidemiological Monitoring of Bacterial Infections
bioMérieux, a world leader in the field of in vitro diagnostics, and Illumina, a world leader in genomics, announced they have signed an exclusive agreement to launch a next-generation sequencing (NGS) epidemiology solution for service labs.
bioMérieux Launches 3P™ Culture Media Range for Cleanrooms and Isolators
bioMérieux Industry, a bioMérieux unit dedicated to industrial application diagnostics, announces the launch of 3PTM, the new culture media product range specifically designed for cleanroom and isolator use. This advanced formulation was co-developed by a bioMérieux international research and development team and designed specifically for environmental monitoring in aseptic manufacturing environments.
BioFire Defense, a bioMérieux Company, Receives Fast-Track Authorization of FilmArray® Ebola Test
BioFire Defense, LLC of Salt Lake City, UT announced today that it has received Emergency Use Authorization by the U.S. Food and Drug Administration (FDA) for its commercial FilmArray® Ebola test (BioThreat-E testTM).
Business Review for the Nine Months Ended September 30, 2014
bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the nine months ended September 30, 2014.
bioMérieux's VITEK MS System Nominated for Prestigious 2014 U.S. Prix Galien Award
The First FDA-Cleared Diagnostic Instrument to Utilize MALDI-TOF Mass Spectrometry to Rapidly Identify Harmful Bacteria and Yeast Recognized by Galien Foundation for Innovation in Healthcare Science
bioMérieux Launches chromID® Salmonella Elite, the New Generation of Culture Media for Earlier Detection of Salmonella Strains in Clinical Fecal Samples
bioMérieux, a world leader in the field of in vitro diagnostics, is pleased to announce the launch of chromID® Salmonella Elite, a new selective chromogenic culture medium for the isolation and rapid identification of Salmonella in stool samples.
bioMérieux Joins with the Rory Staunton Foundation to Host the First National Forum on Sepsis
Event to be held Sept. 17 in Washington D.C. and will feature Sen. Charles E. Schumer (D-NY), Konrad Reinhart, MD, of the Global Sepsis Alliance, Dr. Carl Flatley of the Erin K. Flatley Foundation and Thomas Frieden, MD, Director of the CDC.
Sepsis Awareness Month: Fewer than Half of Americans Have Heard of This Devastating Illness
Despite the fact that sepsis affects more than a million Americans each year and kills up to half of them, a new survey published by Sepsis Alliance found that fewer than half of all Americans have ever even heard of the term ‘sepsis.’
CDC Safe Healthcare Blog: A Mother's Account: "If we had known about sepsis, we would have looked for sepsis."
Today, on CDC’s Safe Healthcare Blog, Orlaith Staunton, mother of 12-year-old sepsis victim Rory Staunton, shares her family’s tragic story in hopes of preventing other families from suffering at the hands of sepsis.